WHAT IS GOING ON AT FOCUSWEST HEALTH?
If you arrived here via www.focuswesthealth.com, you are in the correct place. The FocusWest Health Inc website is under construction.
AI DL RADIOMICS in partnership with the ROBOTIC WIDEFIELD BREAST ULTRASOUND TOMOGRAPHY PLATFORM (patented) (RoWBus™) images the most breast tissue and will safely find breast changes before the human eye. Imaging the most breast tissue without compression, manipulation, or distortion, it is accurate for screening and diagnosis. It is safe, repeatable and comfortable for women of all ages.
FocusWest Health is a startup company whose technological breakthroughs can decrease the mortality of breast cancer for women throughout the world.
The assembled team of international experts in breast imaging, Radiomics, medical ultrasound and clinically is what makes FocusWest Health unique.
Dr Philip Kivitz, a pioneer in the breast imaging/healthcare space, and a board-certified radiologist, becomes the first “primary care physician for the breast” when he envisions, develops, founds and leads the San Francisco Breast Evaluation Center (SFBEC) decades ago. The current technological innovation is based on a prior FDA-approved breast ultrasound device he used for thousands of examinations.
A GLOBAL SOLUTION FOR THE EARLY DETECTION OF BREAST CANCER.
March 2021, the World Health Organization stated that breast is the most common site of cancer worldwide.
FocusWest Health is taking a giant leap forward for the health and wellbeing of women of all ages, their families and their communities wherever they may be.
FocusWest Health is continuing its team building and fund raising.
One Woman’s Story
A 38-year-old woman arrives at the San Francisco Breast Evaluation Center describing a gradually enlarging right breast mass since adolescence. Our whole breast water-bath ultrasound device images reveal her lump to be a benign cyst – a very common breast mass. Our routine is to examine both breasts looking for any other significant occult abnormalities; today, it still is the prudent thing to do. With our innovative ultrasound scanner, it is easy, comfortable for the patient and takes only a few more minutes. An abnormal mass is found in another area of the same breast. This early, unsuspected invasive ductal carcinoma (pathology proven) would have remained undetected until it becomes large enough to feel, possibly spreading to her lymph nodes or later appearing in her mammogram.
— October 1981
It is now generally agreed that mammograms of women with dense breast tissue often miss 20-40% of cancers. Dr Kivitz, because of his deep experience in medical ultrasound starting in his residency, understood that supplemental imaging with a whole breast water bath ultrasound (imaging 99+% of the breast tissue) device can reveal additional early cancers in dense tissue. This is confirmed in his San Francisco Breast Evaluation Center clinical practice supplementing numerous dense breast mammograms with whole breast water bath ultrasound examinations. This original FDA-approved device also differentiates among numerous benign abnormalities. It became an integral part of the SFBEC services, along with the most innovative mammography imaging, ultrasound guided fine needle biopsies, stereotactic fine needle x-ray biopsies and others.
Today, Dr Kivitz brings his extensive experience in breast imaging and breast healthcare to Precision Medicine.
Contact: pghs456@gmail.com.